Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Current Opinion in Hematology|January 31, 2016
Optimal treatment strategies for high-risk acute promyelocytic leukemiaKelly J Norsworthy, Jessica K AltmanCancers|October 14, 2023
Differentiation Syndrome in Acute Leukemia: APL and BeyondAshley C Woods, Kelly J NorsworthyBritish Journal of Haematology|October 10, 2021
Meaningful response criteria for myelodysplastic syndromesNina Kim, Steven Pavletic, Kelly J NorsworthyCase Reports in Hematology|November 5, 2016
Balancing Therapy with Thrombopoietin Receptor Agonists and Splenectomy in Refractory Immune Thrombocytopenic Purpura: A Case of Postsplenectomy Thrombocytosis Requiring PlateletpheresisJacquelyn Zimmerman, Kelly J Norsworthy, Robert BrodskyActa Haematologica|March 24, 2016
Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the LiteratureKelly J Norsworthy, Bhavana Bhatnagar, Zeba N Singh, et al.Journal of Clinical Pharmacology|June 15, 2023
Landscape and Regulatory Perspective on Oncology Drugs in PregnancyRuby Leong, Manuela Grimstein, Peter DeMaria, et al.The Oncologist|April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaKelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.BMC Medicine|November 16, 2007
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneityDenise A Gonzales, Kelly J Norsworthy, Steven J Kern, et al.Investigational New Drugs|February 28, 2013
Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndromeIvana Gojo, Alexander Perl, Selina Luger, et al.Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.Pageof 4